OOIR: Observatory of International Research

Papers

(The H4-Index of Bioscience Reports is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy	122
Gene editing and CRISPR in the clinic: current and future perspectives	121
Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation	117
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19	101
HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose	85
ADSC-Exos containing MALAT1 promotes wound healing by targeting miR-124 through activating Wnt/β-catenin pathway	79
Prognostic value of immune checkpoint molecules in breast cancer	78
Epithelial–mesenchymal transition and its transcription factors	77
A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity	77
Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition	72
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6	72
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer	71
Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling	56
Current knowledge and recent advances in understanding metabolism of the model cyanobacterium Synechocystis sp. PCC 6803	55
Stigmasterol alleviates cerebral ischemia/reperfusion injury by attenuating inflammation and improving antioxidant defenses in rats	54
Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking	51
Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical	49
Biological efficacy of zinc oxide nanoparticles against diabetes: a preliminary study conducted in mice	47
From sepsis to acute respiratory distress syndrome (ARDS): emerging preventive strategies based on molecular and genetic researches	45
The relationship between intestinal goblet cells and the immune response	43
Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications	42
Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma	38
RNA-seq reveals the circular RNA and miRNA expression profile of peripheral blood mononuclear cells in patients with rheumatoid arthritis	38
Epigenetic modification and therapeutic targets of diabetes mellitus	38
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma	37

m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma	36
The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis	36
Exosomes derived from circRNA Rtn4-modified BMSCs attenuate TNF-α-induced cytotoxicity and apoptosis in murine MC3T3-E1 cells by sponging miR-146a	36
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases	36
Apelin-13 alleviated cardiac fibrosis via inhibiting the PI3K/Akt pathway to attenuate oxidative stress in rats with myocardial infarction-induced heart failure	35
Icariin inhibits the inflammation through down-regulating NF-κB/HIF-2α signal pathways in chondrocytes	34
MiR-22-3p suppresses sepsis-induced acute kidney injury by targeting PTEN	34
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer	33